Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009

AIDS Research and Human Retroviruses

Volumn 28, Issue 10, 2012, Pages 1265-1272

  Carneiro Proietti, Anna Bárbara F ^a   Sabino, Ester C ^b   Leão, Silvana ^c   Salles, Nanci A ^b   Loureiro, Paula ^c   Sarr, Moussa ^d   Wright, David ^d   Busch, Michael ^e   Proietti, Fernando A ^f   Murphy, Edward L ^g  

^a Hemominas Foundation   (Brazil)

^b Pró Sangue Foundation Institute for Investigation in Immunology Iii INCT   (Brazil)

^c Hemope Foundation   (Brazil)

^d WESTAT   (United States)

^e BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^f FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BRAZIL; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; EDUCATION; ENZYME IMMUNOASSAY; GENDER; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; SKIN COLOR; SOCIOECONOMICS; VIRUS TRANSMISSION; WESTERN BLOTTING;

ADOLESCENT; ADULT; BLOOD DONORS; BLOOD TRANSFUSION; BRAZIL; DONOR SELECTION; FEMALE; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RISK FACTORS; SENTINEL SURVEILLANCE; YOUNG ADULT;

EID: 84866645720     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0143     Document Type: Article

References (28)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, and Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
2. Kalyanaraman VS, Sarngadharan MG, and Robert-Guroff M: A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-573.
3. Wiktor SZ, Alexander SS, Shaw GM, Weiss SH, Murphy EL, Wilks RJ, Shortly VJ, Hanchard B, and Blattner WA: Distinguishing between HTLV-I and HTLV-II by Western blot. Lancet 1990;335:1533.
4. Andrade RG, Ribeiro MA, Namen-Lopes MS, Silva SM, Basques FV, Ribas JG, Carneiro-Proietti AB, and Martins ML: Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors. Rev Soc Bras Med Trop 2010;43:111-115.
5. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, and Murphy EL: Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005;24:6058-6068.
6. Carneiro-Proietti AB, Ribas JG, Catalan-Soares BC, Martins ML, Brito-Melo GE, Martins-Filho OA, Pinheiro SR, Araújo Ade Q, Galvão-Castro B, de Oliveira MS, Guedes AC, and Proietti FA: Infection and disease caused by the human T cell lymphotropic viruses type I and II in Brazil. Rev Soc Bras Med Trop 2002;35:499-508.
7. Carneiro-Proietti ABF, Catalan-Soares BC, Castro-Costa CM, et al.: HTLV in the Americas: Challenges and perspectives. Pan Am J Public Health 2006;19:44-53.
8. Murphy E L, Figueroa J P, Gibbs WN, Holding-Cobham M, Cranston B, Malley K, Bodner AJ, Alexander SS, and Blattner WA: Human T-lymphotropic virus type I (HTLV-I) ser-oprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 1991;133:1114-1124.
9. Gotuzzo E, Arango C, de Queiroz-Campos A, and Istúriz RE: Human T-cell lymphotropic virus-I in Latin America. Infect Dis Clin North Am 2000;14:211-239.
10. Gonçalves DU, Proietti FA, Ribas JG, Araújo MG, Pinheiro SR, Guedes AC, and Carneiro-Proietti AB: Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 2010;23:577-589.
11. Roucoux DF and Murphy EL: The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 2004;6:144-154.
12. Manns A, Hisada M, and La Grenade L: Human T-lym-photropic virus type I infection. Lancet 1999;353:1951-1958.
13. Biswas HH, Kaidarova Z, Garratty G, Gibble JW, Newman BH, Smith JW, Ziman A, Fridey JL, Sacher RA, Murphy EL, and the HTLV Outcomes Study: Increased all-cause and cancer mortality in HTLV-II infection. J Acquir Immune Defic Syndr 2010;54:290-296.
14. Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, Newman B, Ownby HE, Garratty G, Hutching ST, and Schreiber GB: Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis 2004;10:109-116.
15. Galvão-Castro B, Loures L, Rodrigues LG, et al.: Distribution of human lymphotropic vírus type 1 among blood donors: A nationwide Brazilian study. Transfusion 1997;37:242-243.
16. Catalan-Soares B, Carneiro-Proietti AB, Proietti FA, GIPH: Heterogeneous geographical distribution of human T cell lymphotropic viruses I and II (HTLV-I/II): Serological screening prevalence rates in blood donors from large urban areas in Brazil. CSP-Cadernos de Saúde Pública 2005;21: 926-931.
17. Carrazzone CFV, Verçosa AFA, Lorena VMB, Melo MFAD, Machado RCA, Pinto MBDA, Brito AM, and Gomes YM: Screening of diseases transmissible by blood in recipients prior to transfusion at a university hospital in the Northeast of Brazil. Rev Brasil Hematol Hemoter 2006;28:24-27.
18. Carneiro-Proietti ABF, Sabino, EC, Sampaio D, Proietti FA, Gonçales TT, Oliveira CDL, Ferreira JE, Liu J, Custer B, Schreiber GB, Murphy E, and Busch MP: Demographic profile of blood donors at three major Brazilian blood centers: Results from the International REDS-II study, 2007 to 2008. Transfusion 2010;50:919-925.
19. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, et al.: Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991-1996, JAMA 2000;284:229-235.
20. Schreiber GB, Busch MP, Kleinman SH, and Korelitz JJ: The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-1690.
21. Murphy EL, Watanabe K, Nass CC, Ownby H, Williams A, and Nemo G: Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. J Infect Dis 1999;180:1777-1783.
22. Taylor GP: The epidemiology of HTLV-I in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(Suppl 1):S8-14.
23. Tseliou PM, Spanakis N, Spiliotakara A, Politis C, Legakis NJ, and Tsakris A: HTLV-I and-II in southwestern Greece. Transfusion 2003;43:1641-1642.
24. Maresch C, Schluter PJ, Wilson AD, and Sleigh A: Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil. Transfusion 2008;48:273-281.
25. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, and Sher G: Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 2003;169:767-773.
26. Oliveira CDL, Loureiro F, Bastos, MRD, Proietti FA, and Carneiro-Proietti ABF: Blood donor deferral in Minas Gerais State, Brazil: Blood centers as sentinels of urban population health Transfusion 2009;49:851-857.
27. Seed CR, Margaritis AR, Bolton WV, Kiely P, Parker S, and Piscitelli L: Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays. Transfusion 2003;43:226-234.
28. Morimoto HK, Morimoto AA, Reiche EM, Ueda LT, Matsuo T, Reiche FV, and Caterino-de-Araujo A: Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: Comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype. Rev Inst Med Trop São Paulo 2007;49:225-230.